Atlas Trials

Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT01124708 · COMPLETED

Trial details

NCT number
NCT01124708
Sponsor
Targacept Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ADHD
Start date
2010-05-01
Primary completion
2011-02-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.